Lineage Cell Therapeutics Files 8-K
Ticker: LCTX · Form: 8-K · Filed: May 1, 2025 · CIK: 876343
| Field | Detail |
|---|---|
| Company | Lineage Cell Therapeutics, Inc. (LCTX) |
| Form Type | 8-K |
| Filed Date | May 1, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-k, disclosure
Related Tickers: LCTX
TL;DR
LCTX filed an 8-K on 5/1/25 for an 'Other Event' - details TBD.
AI Summary
Lineage Cell Therapeutics, Inc. filed an 8-K on May 1, 2025, reporting an "Other Event." The filing does not contain specific details about the event itself, but it confirms the company's reporting status and principal executive offices located at 2173 Salk Avenue, Suite 200, Carlsbad, California.
Why It Matters
This filing indicates a material event has occurred for Lineage Cell Therapeutics, Inc., requiring public disclosure under SEC regulations.
Risk Assessment
Risk Level: low — The filing is a standard procedural disclosure and does not contain information that inherently increases risk.
Key Players & Entities
- Lineage Cell Therapeutics, Inc. (company) — Registrant
- May 01, 2025 (date) — Date of earliest event reported
- 2173 Salk Avenue, Suite 200, Carlsbad, California 92008 (location) — Principal Executive Offices
- 001-12830 (other) — Commission File Number
FAQ
What specific event is Lineage Cell Therapeutics, Inc. reporting in this 8-K filing?
The filing states 'Other Events' as the item information, but does not provide specific details about the nature of the event.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on May 01, 2025.
What is the principal executive office address for Lineage Cell Therapeutics, Inc.?
The principal executive offices are located at 2173 Salk Avenue, Suite 200, Carlsbad, California 92008.
What is the Commission File Number for Lineage Cell Therapeutics, Inc.?
The Commission File Number is 001-12830.
What is the IRS Employer Identification Number (EIN) for Lineage Cell Therapeutics, Inc.?
The IRS Employer Identification Number is 94-3127919.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 1, 2025 regarding Lineage Cell Therapeutics, Inc. (LCTX).